The topic that was researched as selected was related descriptive statistics and titled as “Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed after Chemotherapy for Metastatic Disease”
The purpose of this research was to explore the Overexpression of the HER2 protein occurs in 25% to 30% of human breast cancers and leads to a particularly aggressive form of the disease. Efficacy and security of recombinant humanized anti-HER2 monoclonal antibody as a lone agency was assessed in women with HER2-overexpressing metastatic breast cancerous diseaseous ...